27 related articles for article (PubMed ID: 35209962)
1. alphaB-crystallin: a novel p53-target gene required for p53-dependent apoptosis.
Watanabe G; Kato S; Nakata H; Ishida T; Ohuchi N; Ishioka C
Cancer Sci; 2009 Dec; 100(12):2368-75. PubMed ID: 19799611
[TBL] [Abstract][Full Text] [Related]
2. Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research.
Espinosa Fernandez JR; Eckhardt BL; Lee J; Lim B; Pearson T; Seitz RS; Hout DR; Schweitzer BL; Nielsen TJ; Lawrence OR; Wang Y; Rao A; Ueno NT
PLoS One; 2020; 15(4):e0231953. PubMed ID: 32353087
[TBL] [Abstract][Full Text] [Related]
3. Multimodal imaging of metabolic activities for distinguishing subtypes of breast cancer.
Li Z; Nguyen C; Jang H; Hoang D; Min S; Ackerstaff E; Koutcher JA; Shi L
Biomed Opt Express; 2023 Nov; 14(11):5764-5780. PubMed ID: 38021123
[TBL] [Abstract][Full Text] [Related]
4. Effects of the CRYAB gene on stem cell-like properties of colorectal cancer and its mechanism.
Dai A; Guo X; Yang X; Li M; Fu Y; Sun Q
J Cancer Res Ther; 2022 Sep; 18(5):1328-1337. PubMed ID: 36204880
[TBL] [Abstract][Full Text] [Related]
5. Increased chaperone activity of human αB-crystallin with incomplete oxidation as a new defense mechanism against oxidative stress.
Ghahramani M; Shahsavani MB; Yousefi R
Biochim Biophys Acta Proteins Proteom; 2022 Jul; 1870(7):140794. PubMed ID: 35643282
[TBL] [Abstract][Full Text] [Related]
6. Cluster analyses of the TCGA and a TMA dataset using the coexpression of HSP27 and CRYAB improves alignment with clinical-pathological parameters of breast cancer and suggests different epichaperome influences for each sHSP.
Quinlan PR; Figeuredo G; Mongan N; Jordan LB; Bray SE; Sreseli R; Ashfield A; Mitsch J; van den Ijssel P; Thompson AM; Quinlan RA
Cell Stress Chaperones; 2021 Mar; 27(2):177-188. PubMed ID: 35235182
[TBL] [Abstract][Full Text] [Related]
7. αB-Crystallin Phosphorylation: Advances and Problems.
Muranova LK; Sudnitsyna MV; Gusev NB
Biochemistry (Mosc); 2018 Oct; 83(10):1196-1206. PubMed ID: 30472957
[TBL] [Abstract][Full Text] [Related]
8. Dynamical structure of αB-crystallin.
Hochberg GK; Benesch JL
Prog Biophys Mol Biol; 2014 Jul; 115(1):11-20. PubMed ID: 24674783
[TBL] [Abstract][Full Text] [Related]
9. Alpha-crystallin B chains enhance cell migration in basal-like 2 triple-negative breast cancer cells.
Yang L; Higashisaka K; Haga Y; Tsujino H; Nagano K; Tsutsumi Y
Pharmazie; 2022 Feb; 77(2):45-47. PubMed ID: 35209962
[TBL] [Abstract][Full Text] [Related]
10. Fluorouracil exacerbates alpha-crystallin B chain-mediated cell migration in triple-negative breast cancer cell lines.
Yang L; Haga Y; Nishimura A; Tsujii Y; Tanahashi S; Tsujino H; Higashisaka K; Tsutsumi Y
Sci Rep; 2023 Mar; 13(1):4010. PubMed ID: 36899050
[TBL] [Abstract][Full Text] [Related]
11. αB-crystallin: a novel regulator of breast cancer metastasis to the brain.
Malin D; Strekalova E; Petrovic V; Deal AM; Al Ahmad A; Adamo B; Miller CR; Ugolkov A; Livasy C; Fritchie K; Hamilton E; Blackwell K; Geradts J; Ewend M; Carey L; Shusta EV; Anders CK; Cryns VL
Clin Cancer Res; 2014 Jan; 20(1):56-67. PubMed ID: 24132917
[TBL] [Abstract][Full Text] [Related]
12. αB-crystallin expression is correlated with phospho-ERK1/2 expression in human breast cancer.
van de Schootbrugge C; van Asten F; Nagtegaal ID; Versleijen-Jonkers YM; van Laarhoven HW; Roeffen MH; Sweep FC; Bussink J; Kaanders JH; Pruijn GJ; Boelens WC; Span PN
Int J Biol Markers; 2013 Dec; 28(4):e365-70. PubMed ID: 23722303
[TBL] [Abstract][Full Text] [Related]
13. AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer.
Moyano JV; Evans JR; Chen F; Lu M; Werner ME; Yehiely F; Diaz LK; Turbin D; Karaca G; Wiley E; Nielsen TO; Perou CM; Cryns VL
J Clin Invest; 2006 Jan; 116(1):261-70. PubMed ID: 16395408
[TBL] [Abstract][Full Text] [Related]
14. Discovery of structure-based small molecular inhibitor of αB-crystallin against basal-like/triple-negative breast cancer development in vitro and in vivo.
Chen Z; Ruan Q; Han S; Xi L; Jiang W; Jiang H; Ostrov DA; Cai J
Breast Cancer Res Treat; 2014 May; 145(1):45-59. PubMed ID: 24710637
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
